Literature DB >> 12805384

STAT4 requires the N-terminal domain for efficient phosphorylation.

Hua-Chen Chang1, Shangming Zhang, India Oldham, Lisa Naeger, Timothy Hoey, Mark H Kaplan.   

Abstract

STAT4 (signal transducer and activator of transcription-4) mediates biological effects in response to interleukin-12 (IL-12). STAT4 has multiple domains that have distinct functions in signaling and gene activation. To characterize the role of the STAT4 N-terminal domain in mediating STAT4 biological function, we have generated STAT4-deficient transgenic mice that express human full-length STAT4 or an N-terminal deletion mutant (Delta N-STAT4) lacking the N-terminal 51 amino acids. Whereas full-length STAT4 rescued IL-12 responsiveness, T lymphocytes expressing the STAT4 N-terminal mutant failed to proliferate in response to IL-12 and had limited Th1 cell development as evidenced by minimal interferon-gamma production. Deletion of the N-terminal domain resulted in failure of STAT4 to be phosphorylated following IL-12 stimulation despite similar phosphorylation of JAK2 and TYK2 in full-length STAT4 and Delta N-STAT4 transgenic T cells. We demonstrate that the lack of phosphorylation in cultured cells is due to reduced efficiency of phosphorylation of Delta N-STAT4 by Janus kinases. These data support a new model wherein the N-terminal domain is required to mediate the phosphorylation of STAT4 in addition to the previously documented role in gene transactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805384     DOI: 10.1074/jbc.M302776200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.

Authors:  Laura A Ekas; Timothy J Cardozo; Maria Sol Flaherty; Elizabeth A McMillan; Foster C Gonsalves; Erika A Bach
Journal:  Dev Biol       Date:  2010-05-23       Impact factor: 3.582

2.  Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma.

Authors:  Michael J Robertson; Hua-Chen Chang; David Pelloso; Mark H Kaplan
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

3.  Investigation of the interaction between CREB-binding protein and STAT4/STAT6.

Authors:  Mingxiang Zhang; Zhou Fu; Daiyin Tian; Enmei Liu; Jihong Dai; Lijia Wang
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

4.  IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.

Authors:  Ling Zhang; Donna B Badgwell; Jack J Bevers; Karni Schlessinger; Peter J Murray; David E Levy; Stephanie S Watowich
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

5.  Pre-assembly of STAT4 with the human IFN-alpha/beta receptor-2 subunit is mediated by the STAT4 N-domain.

Authors:  Douglas R Tyler; Meredith E Persky; Loderick A Matthews; Sheuwen Chan; J David Farrar
Journal:  Mol Immunol       Date:  2006-11-13       Impact factor: 4.407

6.  IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines.

Authors:  Ayele-Nati N Ahyi; Hua-Chen Chang; Alexander L Dent; Stephen L Nutt; Mark H Kaplan
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

7.  The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.

Authors:  Tieying Hou; Sutapa Ray; Chang Lee; Allan R Brasier
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

8.  Impaired development of human Th1 cells in patients with deficient expression of STAT4.

Authors:  Hua-Chen Chang; Ling Han; Ritobrata Goswami; Evelyn T Nguyen; David Pelloso; Michael J Robertson; Mark H Kaplan
Journal:  Blood       Date:  2009-04-09       Impact factor: 22.113

9.  PU.1 regulates TCR expression by modulating GATA-3 activity.

Authors:  Hua-Chen Chang; Ling Han; Rukhsana Jabeen; Sebastian Carotta; Stephen L Nutt; Mark H Kaplan
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 10.  STAT heterodimers in immunity: A mixed message or a unique signal?

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  JAKSTAT       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.